- Xconomy Network:
- Xconomy National
- About
- Contact Us
- Archives
- Advertise
- Reprints
- E-mail - RSS
Archives
| Entry | Blogger | Date | Location | |
|---|---|---|---|---|
| Ariad CEO Fires Back at Resigning Directors and Their “False and Misleading” Attacks | Luke Timmerman | 12/08/08 | Boston | |
| Ariad Gets $12.5M From Merck For Beginning Cancer Trial | Luke Timmerman | 10/20/08 | Boston | |
| Ariad Pharmaceuticals Edging Toward Becoming a Commercial Cancer Drug Company | Luke Timmerman | 09/02/08 | Boston | |
| Ariad Begins Clinical Trial of Breast Cancer Drug | Luke Timmerman | 07/30/08 | Boston | |
| Page 1 of 1 | ||||
UNDERWRITERS AND PARTNERS
ADVERTISEMENT
Most Popular Stories
ADVERTISEMENT
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.
© 2007-2009, Xconomy, Inc.
XCONOMY is a registered service mark of Xconomy, Inc.
All rights reserved.
Site designed by
Matthew Bouchard, produced by
Andrew Koyfman,
and powered by WordPress.